FOXO3 rs12212067: What Your Genotype Means
The rs12212067 variant is a common genetic change located in the FOXO3 gene. It is associated with differences in how the body regulates inflammatory responses, which may influence the clinical course of certain autoimmune conditions.
What each genotype means
Typical ovarian reserve profile
You carry two copies of the common T allele at rs12212067 in the FOXO3 gene. This genotype is typically associated with baseline rates of primordial follicle activation and average reproductive timing parameters in population studies. Evidence linking this specific intronic variant directly to differences in ovarian reserve remains limited and preliminary.
Carried by approximately 35% to 40% of individuals of European ancestry, and represents the most common genotype in many global populations.
Intermediate ovarian reserve variation
You carry one copy of the G allele and one copy of the T allele at rs12212067. Because FOXO3 plays a critical role in preserving the dormant ovarian follicle pool, carrying this regulatory variant has been tentatively linked to slight variations in ovarian reserve markers and timing of reproductive senescence. However, scientific evidence for this specific association is limited and not diagnostic of personal fertility.
Carried by approximately 45% to 50% of individuals of European ancestry.
Altered ovarian reserve markers
You carry two copies of the minor G allele at rs12212067. Research indicates this regulatory FOXO3 polymorphism may subtly modulate gene expression related to primordial follicle maintenance and ovarian reserve lifespan. Because published evidence remains limited, these statistical observations should not be interpreted as a forecast of fertility or reproductive lifespan.
Carried by approximately 12% to 16% of individuals of European ancestry.
Understanding the rs12212067 Variant
The rs12212067 variant is a single-nucleotide polymorphism (SNP) located within the FOXO3 gene on chromosome 6. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is classified as noncoding, meaning it does not alter the protein sequence itself but instead influences how the gene is expressed or transcribed. Research indicates that the presence of the minor allele (G) at this position is associated with increased transcription of the FOXO3 gene. Because this variant is common in the general population, it has been the subject of various studies investigating how subtle genetic differences can influence biological pathways, particularly those involved in the immune system's response to stress and inflammation.
The Role of the FOXO3 Gene
The FOXO3 gene encodes the FOXO3 protein, which belongs to the forkhead box O family of transcription factors. These proteins act as master regulators, controlling the expression of many other genes involved in critical cellular processes such as metabolism, cell-cycle control, and apoptosis (programmed cell death). Beyond these fundamental roles, FOXO3 is a key player in immune regulation. It helps modulate the activity of monocytes—a type of white blood cell—by influencing the production of cytokines. Cytokines are signaling molecules that coordinate the body's inflammatory response. By regulating the balance between pro-inflammatory and anti-inflammatory cytokines, FOXO3 helps ensure that the immune system responds appropriately to threats without causing excessive or prolonged damage to healthy tissues.
Research Associations and Evidence Strength
Scientific research has linked the rs12212067 variant to the prognosis of several inflammatory conditions, including rheumatoid arthritis and Crohn's disease. Studies suggest that individuals carrying the minor (G) allele may experience a milder disease course, likely because the increased FOXO3 transcription helps limit excessive inflammation through a TGFβ1-dependent pathway. However, the evidence for these associations is considered limited. While some cohorts show a clear link between the variant and reduced disease activity, these findings have not been consistently replicated across all populations or disease settings. Furthermore, some studies have reported conflicting results, such as an association with increased risk of severe malaria or, in specific populations like the Eastern Chinese Han, a potential correlation with elevated risk for ankylosing spondylitis. These mixed results highlight the complexity of genetic associations, which can vary significantly based on ancestry and environmental factors.
Population Frequency
The rs12212067 variant is considered a common polymorphism, meaning it is found at a significant frequency across diverse human populations. Global data indicates that the minor allele (G) is present in a substantial portion of the population, though exact frequencies can fluctuate depending on the specific ancestral group being studied.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs12212067 are only one piece of a much larger puzzle. While research has identified statistical associations between this variant and certain health outcomes, these findings are based on population-level data and cannot predict an individual's specific health trajectory. Many factors, including environment, lifestyle, and other genetic markers, play a much larger role in determining health and disease risk. This information is intended for educational purposes only and should not be used to make medical decisions or to diagnose any condition. If you have concerns about your health, symptoms of an inflammatory condition, or questions about how your genetics might influence your medical care, please consult with a qualified healthcare professional or a genetic counselor who can provide personalized guidance.
How common is this variant?
The rs12212067 variant is a common polymorphism found across diverse human populations, with the minor allele (G) occurring at a frequency of approximately 13% in many global datasets.
Frequently asked questions
Does having the G allele mean I will not get rheumatoid arthritis?
No. Research suggests that this variant is associated with the prognosis or severity of the disease rather than the initial susceptibility or risk of developing it.
Can I use this SNP to predict my health outcomes?
No. Genetic associations are based on statistical trends in large groups and cannot predict individual health outcomes. Many other factors, including lifestyle and environment, are far more influential.
Is this variant related to longevity?
While the FOXO3 gene is well-known for its association with human longevity, the specific longevity-associated variants are often different from the rs12212067 variant discussed here.
Should I change my medication based on this result?
Absolutely not. Never change your medication or treatment plan based on genetic test results without first consulting your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 10/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12212067?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Non-coding FOXO3 variant identified in longitudinal aging studies as conferring an advantage for survival from midlife into advanced old age.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.